111 related articles for article (PubMed ID: 35632779)
1. Signaling Pathway Reporter Screen with SARS-CoV-2 Proteins Identifies nsp5 as a Repressor of p53 Activity.
Kumar A; Grams TR; Bloom DC; Toth Z
Viruses; 2022 May; 14(5):. PubMed ID: 35632779
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species.
Moustaqil M; Ollivier E; Chiu HP; Van Tol S; Rudolffi-Soto P; Stevens C; Bhumkar A; Hunter DJB; Freiberg AN; Jacques D; Lee B; Sierecki E; Gambin Y
Emerg Microbes Infect; 2021 Dec; 10(1):178-195. PubMed ID: 33372854
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 nsp5 Exhibits Stronger Catalytic Activity and Interferon Antagonism than Its SARS-CoV Ortholog.
Chen J; Li Z; Guo J; Xu S; Zhou J; Chen Q; Tong X; Wang D; Peng G; Fang L; Xiao S
J Virol; 2022 Apr; 96(8):e0003722. PubMed ID: 35389264
[TBL] [Abstract][Full Text] [Related]
4. Interaction of HDAC2 with SARS-CoV-2 NSP5 and IRF3 Is Not Required for NSP5-Mediated Inhibition of Type I Interferon Signaling Pathway.
Naik NG; Lee SC; Veronese BHS; Ma Z; Toth Z
Microbiol Spectr; 2022 Oct; 10(5):e0232222. PubMed ID: 36173315
[TBL] [Abstract][Full Text] [Related]
5. Proteolytic cleavage and inactivation of the TRMT1 tRNA modification enzyme by SARS-CoV-2 main protease.
Zhang K; Eldin P; Ciesla JH; Briant L; Lentini JM; Ramos J; Cobb J; Munger J; Fu D
Elife; 2024 May; 12():. PubMed ID: 38814682
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Nsp5 Activates NF-κB Pathway by Upregulating SUMOylation of MAVS.
Li W; Qiao J; You Q; Zong S; Peng Q; Liu Y; Hu S; Liu W; Li S; Shu X; Sun B
Front Immunol; 2021; 12():750969. PubMed ID: 34858407
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 main protease suppresses type I interferon production by preventing nuclear translocation of phosphorylated IRF3.
Fung SY; Siu KL; Lin H; Yeung ML; Jin DY
Int J Biol Sci; 2021; 17(6):1547-1554. PubMed ID: 33907518
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation of stress granules.
Zheng Y; Deng J; Han L; Zhuang MW; Xu Y; Zhang J; Nan ML; Xiao Y; Zhan P; Liu X; Gao C; Wang PH
Signal Transduct Target Ther; 2022 Jan; 7(1):22. PubMed ID: 35075101
[TBL] [Abstract][Full Text] [Related]
9. Porcine Deltacoronavirus nsp5 Cleaves DCP1A To Decrease Its Antiviral Activity.
Zhu X; Chen J; Tian L; Zhou Y; Xu S; Long S; Wang D; Fang L; Xiao S
J Virol; 2020 Jul; 94(15):. PubMed ID: 32461317
[TBL] [Abstract][Full Text] [Related]
10. Predicted coronavirus Nsp5 protease cleavage sites in the human proteome.
Scott BM; Lacasse V; Blom DG; Tonner PD; Blom NS
BMC Genom Data; 2022 Apr; 23(1):25. PubMed ID: 35379171
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 NSP12 Protein Is Not an Interferon-β Antagonist.
Li A; Zhao K; Zhang B; Hua R; Fang Y; Jiang W; Zhang J; Hui L; Zheng Y; Li Y; Zhu C; Wang PH; Peng K; Xia Y
J Virol; 2021 Aug; 95(17):e0074721. PubMed ID: 34133897
[TBL] [Abstract][Full Text] [Related]
12. Protease cleavage of RNF20 facilitates coronavirus replication via stabilization of SREBP1.
Zhang S; Wang J; Cheng G
Proc Natl Acad Sci U S A; 2021 Sep; 118(37):. PubMed ID: 34452991
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the Dimerization and Activity of SARS-CoV-2 Main Protease through Reversible Glutathionylation of Cysteine 300.
Davis DA; Bulut H; Shrestha P; Yaparla A; Jaeger HK; Hattori SI; Wingfield PT; Mieyal JJ; Mitsuya H; Yarchoan R
mBio; 2021 Aug; 12(4):e0209421. PubMed ID: 34399606
[TBL] [Abstract][Full Text] [Related]
14. Identification of Host Cellular Protein Substrates of SARS-COV-2 Main Protease.
Miczi M; Golda M; Kunkli B; Nagy T; Tőzsér J; Mótyán JA
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33333742
[TBL] [Abstract][Full Text] [Related]
15. Transcriptome of nasopharyngeal samples from COVID-19 patients and a comparative analysis with other SARS-CoV-2 infection models reveal disparate host responses against SARS-CoV-2.
Islam ABMMK; Khan MA; Ahmed R; Hossain MS; Kabir SMT; Islam MS; Siddiki AMAMZ
J Transl Med; 2021 Jan; 19(1):32. PubMed ID: 33413422
[TBL] [Abstract][Full Text] [Related]
16. Cell-Based High-Throughput Screening Protocol for Discovering Antiviral Inhibitors Against SARS-COV-2 Main Protease (3CLpro).
Rothan HA; Teoh TC
Mol Biotechnol; 2021 Mar; 63(3):240-248. PubMed ID: 33464543
[TBL] [Abstract][Full Text] [Related]
17. Porcine Deltacoronavirus nsp5 Antagonizes Type I Interferon Signaling by Cleaving STAT2.
Zhu X; Wang D; Zhou J; Pan T; Chen J; Yang Y; Lv M; Ye X; Peng G; Fang L; Xiao S
J Virol; 2017 May; 91(10):. PubMed ID: 28250121
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO.
Wu J; Shi Y; Pan X; Wu S; Hou R; Zhang Y; Zhong T; Tang H; Du W; Wang L; Wo J; Mu J; Qiu Y; Yang K; Zhang LK; Ye BC; Qi N
Cell Rep; 2021 Feb; 34(7):108761. PubMed ID: 33567255
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of Cell Signaling by SARS-CoV-2.
Suryawanshi RK; Koganti R; Agelidis A; Patil CD; Shukla D
Trends Microbiol; 2021 Mar; 29(3):224-237. PubMed ID: 33451855
[TBL] [Abstract][Full Text] [Related]
20. Direct Activation of Endothelial Cells by SARS-CoV-2 Nucleocapsid Protein Is Blocked by Simvastatin.
Qian Y; Lei T; Patel PS; Lee CH; Monaghan-Nichols P; Xin HB; Qiu J; Fu M
J Virol; 2021 Nov; 95(23):e0139621. PubMed ID: 34549987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
